Four companies from Yokohama, Japan are seeking to explore partnerships with US companies through the BIOCOM 2021 Global Life Science Partnering Conference, an annual partnering event which is being held online for the first time this year.
IN 2017, the City of Yokohama concluded a MOU with BIOCOM to promote mutual economic development through life innovation, the same year commemorating the 60th anniversary of Yokohama-San Diego’s sister city relationship. Based on the MOU, the collaborative relationship with BIOCOM has facilitated Yokohama and Yokohama-based companies in joining this conference. The City of Yokohama and Kihara Memorial Foundation support the four companies by offering technical advice by experts in preparation for the conference. The City of Yokohama US office is sponsoring the conference to raise participants’ awareness of the City of Yokohama and to deliver a presentation for the city’s promotion.
BIOCOM 2021 – Participating Companies
ARTham Therapeutics is a clinical stage biopharmaceutical company launched in Yokohama Japan in 2018. Currently their portfolio has 3 clinical stage programs: ART-648, a PDE4 inhibitor for bullous pemphigoid, COVID-19 (P2 ready); ART-001, a PI3Kalpha inhibitor for vascular malformations (P2 ready); ART-002 for underactive bladder (P1 ready)
MediGear International is going to provide a novel drug-free, minimally invasive and a kind of the tumor targeting modality which uses only a biodegradable nano-device, for inoperable cancer patients who have no therapeutic options left, such as after the standard treatments, or in the lower physical strength & immune deficiency.
GlycoTechnica provides a glycan profiling analysis system, GlycoStation™, and services using lectin microarrays and washing-free evanescent-field fluorescence excitation scanners.
MabGenesis expands druggable space by providing first-in-class and best-in-class therapeutic monoclonal antibodies against hard-to-drug targets in human and animal fields.
BIOCOM 2021 – Event Overview
Dates: Tuesday, February 23rd to Thursday, February 25th (PST)
BIOCOM – Organization Overview
Representing over 1,300 member companies to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge workforce development and STEM education programs, and create robust value-driven purchasing programs. Biocom provides the strongest public voice for research institutions and life science companies that fuel the California economy. Established in 1995 in San Diego